DE2134899C3 - Verwendung von N-Äthyl-norscopolaminmethobromid - Google Patents

Verwendung von N-Äthyl-norscopolaminmethobromid

Info

Publication number
DE2134899C3
DE2134899C3 DE2134899A DE2134899A DE2134899C3 DE 2134899 C3 DE2134899 C3 DE 2134899C3 DE 2134899 A DE2134899 A DE 2134899A DE 2134899 A DE2134899 A DE 2134899A DE 2134899 C3 DE2134899 C3 DE 2134899C3
Authority
DE
Germany
Prior art keywords
methobromide
ethyl
norscopolamine
cysteine
ethylnorscopolamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2134899A
Other languages
German (de)
English (en)
Other versions
DE2134899A1 (de
DE2134899B2 (de
Inventor
Helmut Dr. 6507 Ingelheim Wick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CH Boehringer Sohn AG and Co KG
Original Assignee
CH Boehringer Sohn AG and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE786200D priority Critical patent/BE786200A/xx
Application filed by CH Boehringer Sohn AG and Co KG filed Critical CH Boehringer Sohn AG and Co KG
Priority to DE2134899A priority patent/DE2134899C3/de
Priority to ZA724724A priority patent/ZA724724B/xx
Priority to AU44498/72A priority patent/AU470025B2/en
Priority to GB3264572A priority patent/GB1392094A/en
Priority to CA146,913A priority patent/CA988418A/en
Priority to IL39889A priority patent/IL39889A/en
Priority to NLAANVRAGE7209675,A priority patent/NL175493C/xx
Priority to IE989/72A priority patent/IE36952B1/xx
Priority to FR7225511A priority patent/FR2145693B1/fr
Publication of DE2134899A1 publication Critical patent/DE2134899A1/de
Priority to US05/648,729 priority patent/US4016279A/en
Priority to IT49433/79A priority patent/IT1116880B/it
Priority to HK496/79A priority patent/HK49679A/xx
Publication of DE2134899B2 publication Critical patent/DE2134899B2/de
Application granted granted Critical
Publication of DE2134899C3 publication Critical patent/DE2134899C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE2134899A 1971-07-13 1971-07-13 Verwendung von N-Äthyl-norscopolaminmethobromid Expired DE2134899C3 (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BE786200D BE786200A (fr) 1971-07-13 Traitement par inhalation de maladies bronchiques
DE2134899A DE2134899C3 (de) 1971-07-13 1971-07-13 Verwendung von N-Äthyl-norscopolaminmethobromid
ZA724724A ZA724724B (en) 1971-07-13 1972-07-11 Pharmaceutical compositions for treatment of bronchial diseases
GB3264572A GB1392094A (en) 1971-07-13 1972-07-12 Aerosal bronchodilator compositions
CA146,913A CA988418A (en) 1971-07-13 1972-07-12 Agents for inhalation therapy of bronchial diseases
IL39889A IL39889A (en) 1971-07-13 1972-07-12 Inhalant compositions containing an anticholinergically active compound and inhalers for the administration thereof
AU44498/72A AU470025B2 (en) 1971-07-13 1972-07-12 Aerosal bronchodilator
NLAANVRAGE7209675,A NL175493C (nl) 1971-07-13 1972-07-13 Werkwijze voor het bereiden van een inhaleermiddel ter behandeling van ziekten van de ademhalingswegen.
IE989/72A IE36952B1 (en) 1971-07-13 1972-07-13 Aerosol bronchodilator compositions
FR7225511A FR2145693B1 (enExample) 1971-07-13 1972-07-13
US05/648,729 US4016279A (en) 1971-07-13 1976-01-13 Spray compositions for inhalation therapy of bronchial disorders
IT49433/79A IT1116880B (it) 1971-07-13 1979-06-15 Composizioni farmaceutiche spray per inalazioni e relativo procedimento di preparazione
HK496/79A HK49679A (en) 1971-07-13 1979-07-19 Aerosol bronchodilator compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2134899A DE2134899C3 (de) 1971-07-13 1971-07-13 Verwendung von N-Äthyl-norscopolaminmethobromid

Publications (3)

Publication Number Publication Date
DE2134899A1 DE2134899A1 (de) 1973-02-01
DE2134899B2 DE2134899B2 (de) 1980-07-10
DE2134899C3 true DE2134899C3 (de) 1981-04-02

Family

ID=5813500

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2134899A Expired DE2134899C3 (de) 1971-07-13 1971-07-13 Verwendung von N-Äthyl-norscopolaminmethobromid

Country Status (13)

Country Link
US (1) US4016279A (enExample)
AU (1) AU470025B2 (enExample)
BE (1) BE786200A (enExample)
CA (1) CA988418A (enExample)
DE (1) DE2134899C3 (enExample)
FR (1) FR2145693B1 (enExample)
GB (1) GB1392094A (enExample)
HK (1) HK49679A (enExample)
IE (1) IE36952B1 (enExample)
IL (1) IL39889A (enExample)
IT (1) IT1116880B (enExample)
NL (1) NL175493C (enExample)
ZA (1) ZA724724B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4183912A (en) * 1978-01-16 1980-01-15 American Home Products Corporation Inhalation therapy for relieving bronchial spasm using quaternary salts of promethazine
IT1164227B (it) * 1983-05-13 1987-04-08 Angeli Inst Spa Composizione farmaceutica atta alla somministrazione nasale di sali quaternari d'ammonio ed attivita' anticolinergica
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
RU2684761C1 (ru) * 2018-02-20 2019-04-12 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СибГМУ Минздрава России) Способ профилактики респираторных осложнений у пациентов после хирургического лечения рака легкого

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2753288A (en) * 1953-01-12 1956-07-03 Upjohn Co Scopolamine lower-alkyl halide therapeutic composition
US3169095A (en) * 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
DE1670048C3 (de) * 1966-01-26 1980-09-04 C.H. Boehringer Sohn, 6507 Ingelheim Neue Norscopolaminderivate

Also Published As

Publication number Publication date
IL39889A (en) 1976-05-31
ZA724724B (en) 1974-03-27
AU4449872A (en) 1974-01-17
IE36952L (en) 1973-01-13
FR2145693B1 (enExample) 1976-03-05
AU470025B2 (en) 1976-03-04
GB1392094A (en) 1975-04-23
IL39889A0 (en) 1972-09-28
BE786200A (fr) 1973-01-12
NL175493B (nl) 1984-06-18
HK49679A (en) 1979-07-27
IT1116880B (it) 1986-02-10
NL7209675A (enExample) 1973-01-16
CA988418A (en) 1976-05-04
IT7949433A0 (it) 1979-06-15
IE36952B1 (en) 1977-03-30
DE2134899A1 (de) 1973-02-01
DE2134899B2 (de) 1980-07-10
US4016279A (en) 1977-04-05
FR2145693A1 (enExample) 1973-02-23
NL175493C (nl) 1984-11-16

Similar Documents

Publication Publication Date Title
DE69920734T2 (de) Verfahren und zusammensetzungen zur vorbeugung von toleranz gegenüber bronchodilatoren
DE69807239T2 (de) Neue verwendung von budesonide und formoterol
DE60019167T2 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
DE3413052A1 (de) Pharmazeutische zubereitung und deren verwendung zur behandlung von hauterkrankungen
DE1670827B2 (de) 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-di carbmethoxy-1,4-dihydropyridin
DE4037708A1 (de) Appetitzuegler und verfahren zu seiner anwendung
CH685672A5 (de) Beta(2)-Bronchienerweiternde Arzneistoffe in Form ihrer bronchienerweiternden Enantiomeren zur Verwendung für die Herstellung eines Mittels zur verbesserten Therapie.
EP0321817B1 (de) Verwendung von Bisguanide enthaltenden Zusammensetzungen gegen Eier des Madenwurms
DE2134899C3 (de) Verwendung von N-Äthyl-norscopolaminmethobromid
WO1996037198A1 (de) Inhalative verwendung von antidepressiva zur behandlung von asthma
DE69834638T2 (de) Zusammensetzung zur Behandlung von Augenhypertension oder Glaukom
DE2903957A1 (de) Mittel zur behandlung der nasalen hypersekretion
DE2721259C2 (enExample)
EP0003750B1 (de) Salze von Dithiodialkansulfonsäuren zur Verwendung bei der cytostatischen Therapie mit Alkylantien
DE3852717T2 (de) Zusammensetzung für die Prophylaxe von Pneumocystis-carinii-Pneumonie.
EP0022426B1 (de) Nasalpräparate und Verfahren zu deren Herstellung
DE3339052A1 (de) Pharmazeutisches praeparat zur verbesserung der biochemischen und verhaltens-parameter bei senilitaet
DE3027056A1 (de) Pharmazeutischer ansatz zur verwendung als schutz gegen akutes lungenoedem, anaphylaktischen schock u.a. arten von schock sowie hyperfibrinolyse
WO1996002252A1 (de) VERWENDUNG VON (S)-ADENOSYL-L-METHIONIN (SAMe) UND DESSEN PHYSIOLOGISCH VERTRÄGLICHEN SALZEN ZUR BEHANDLUNG VON REPERFUSIONSSCHÄDEN, DIE DURCH TEMPORÄRE FOKALE ISCHÄMIE AUSGELÖST WERDEN
DE2347531A1 (de) Arzneizubereitungen zur oralen diabetes-behandlung
EP0213108A2 (de) Pharmazeutische Zubereitung mit einem Antihypotonikum als wirksames Mittel
DE2801867A1 (de) Antikoagulans-arzneimittel auf der basis von heparin
DE2533140B2 (de) Verwendung von D-Glucuronsäure bzw. deren γ -Lacton
DE2161588B2 (de) Mittel zur behandlung von hyperlipoproteinaemien
CH677878A5 (enExample)

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)